Description
Protein A Resin Market size was valued at USD 1.32 billion in 2021. It is expected to reach a value of USD 2.05 billion by 2028, growing at a CAGR of 6.5% from 2022-28. Protein A is a surface protein that originally found in cell wall of bacteria staphylococcus aureus. It has many applications in biopharmaceutical and biochemical industry especially in monoclonal antibodies purification. Protein A Resin Market is a chromatographic medium that is used to analyse and separate the antibodies. Because of its ability to bind immunoglobulins protein A resin is also used in immunological research. Nowadays protein A resins produced mostly using recombinant DNA technology in Escherichia coli. Companies in Protein A Resin market are investing in research and development to gain the competitive advantage. Additionally, the global industry is developing as a result of a biotechnology and biopharmaceutical industry expansion in the drug development process, growing research into monoclonal antibodies, and rising spending on synthetic biology. In addition, the demand for protein-engineered products utilised in the development of vaccines and medicines by the biopharmaceutical sectors is rising, which is one of the key reasons driving the business globally.
Key Developments:
In February 2016, Repligen Corporation has extended a long term supply agreement with GE Healthcare through 2019 for Protein A ligands manufacturing at its facility in Lund, Sweden.
In June 2017, Purolite, a chemical manufacturing company collaborated with ChromaTan Corporation to develop a novel protein A bead.